| scholarly article | Q13442814 |
| P2093 | author name string | Hiroshi Nakamura | |
| Ai Kozaki | |||
| Toshu Inoue | |||
| P2860 | cites work | Quality of life and occupational disability in endocrine orbitopathy | Q24652695 |
| Clinical features of Graves' ophthalmopathy in an incidence cohort | Q28275743 | ||
| Graves' Disease. | Q30243909 | ||
| Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. | Q34010116 | ||
| Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. | Q35305938 | ||
| Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity | Q37829150 | ||
| A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease | Q37897862 | ||
| Ocular surface changes in thyroid eye disease. | Q45989934 | ||
| Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series | Q46965301 | ||
| A single transcutaneous injection with Botox for dysthyroid lid retraction. | Q47635665 | ||
| Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease. | Q49049760 | ||
| Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. | Q49084302 | ||
| TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients. | Q53272960 | ||
| Proptosis in dysthyroid ophthalmopathy: a case series of 10,931 Japanese cases. | Q53314382 | ||
| Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy | Q57184471 | ||
| Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy | Q68002641 | ||
| Sagittal magnetic resonance imaging of dysthyroid ophthalmopathy | Q70690640 | ||
| Levator palpebrae superioris muscle: MR evaluation of enlargement as a cause of upper eyelid retraction in Graves disease | Q70761049 | ||
| Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements | Q72260946 | ||
| Topical Guanethidine Therapy for Endocrine Lid Retraction | Q72886751 | ||
| Localization and clinical significance of thyrotropin receptor mRNA expression in orbital fat and eye muscle tissues from patients with thyroid-associated ophthalmopathy | Q72991394 | ||
| Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease | Q79885195 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 325-331 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | International Medical Case Reports Journal | Q15817439 |
| P1476 | title | Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease | |
| P478 | volume | 11 |
Search more.